Esperion Therapeutics
Satish Nachaegari has over 18 years of experience in regulatory and clinical affairs, serving in various leadership roles at Esperion since October 2018, including Vice President and Executive Director of Global Regulatory Affairs. Prior experience includes over 13 years at Lipocine Inc. as Associate Director of Regulatory and Clinical Affairs, where responsibilities encompassed clinical study design, regulatory strategy, and submissions to the FDA. Early career experience includes formulation development at Dr. Reddy's Laboratories. Satish holds a Master of Pharmacy in Pharmaceutical Technology from the National Institute of Pharmaceutical Education and Research, a Bachelor of Pharmacy from Kakatiya University, and certifications in clinical pharmacology and regulatory affairs.
This person is not in the org chart
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.